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The Omega-3 Fatty Acid Eicosapentaenoic Acid Is
Required for Normal Alcohol Response Behaviors in C.
elegans
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Abstract
Alcohol addiction is a widespread societal problem, for which there are few treatments. There are significant genetic and
environmental influences on abuse liability, and understanding these factors will be important for the identification of
susceptible individuals and the development of effective pharmacotherapies. In humans, the level of response to alcohol is
strongly predictive of subsequent alcohol abuse. Level of response is a combination of counteracting responses to alcohol,
the level of sensitivity to the drug and the degree to which tolerance develops during the drug exposure, called acute
functional tolerance. We use the simple and well-characterized nervous system of Caenorhabditis elegans to model the acute
behavioral effects of ethanol to identify genetic and environmental factors that influence level of response to ethanol. Given
the strong molecular conservation between the neurobiological machinery of worms and humans, cellular-level effects of
ethanol are likely to be conserved. Increasingly, variation in long-chain polyunsaturated fatty acid levels has been implicated
in complex neurobiological phenotypes in humans, and we recently found that fatty acid levels modify ethanol responses in
worms. Here, we report that 1) eicosapentaenoic acid, an omega-3 polyunsaturated fatty acid, is required for the
development of acute functional tolerance, 2) dietary supplementation of eicosapentaenoic acid is sufficient for acute
tolerance, and 3) dietary eicosapentaenoic acid can alter the wild-type response to ethanol. These results suggest that
genetic variation influencing long-chain polyunsaturated fatty acid levels may be important abuse liability loci, and that
dietary polyunsaturated fatty acids may be an important environmental modulator of the behavioral response to ethanol.
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of LR. Here, we explore a possible role for diet in modulating LR
using the nematode Caenorhabditis elegans.
Caenorhabditis elegans provides a simple system in which to
study the genetic and molecular effects of ethanol intoxication and
LR [8,9]. Intoxication in C. elegans occurs at doses that cause
intoxication in other organisms [10]. Genes that alter responses to
ethanol in the worm also influence ethanol responses in rodents
[8,9,11–14], suggesting that there are conserved mechanisms for
ethanol responses between C. elegans and mammals. Initial LR is
quantitative measure of the degree of intoxication at a particular
alcohol concentration, e.g. alcohol-induced body sway in humans
[6]. There are likely to be multiple physiological factors that
influence LR, including neuronal homeostatic mechanisms acting
in opposition to the drug’s effects. In both mammals and C.
elegans, the measured LR is dependent on both the initial
sensitivity to the effects of the drug and the degree to which
tolerance to those effects develops during the alcohol exposure
[8,9,15–17]. The within-session tolerance is called acute functional
tolerance (AFT); it is observed in C. elegans and mammals,
including humans. Different rates of development of AFT impact

Introduction
Alcohol use disorders (AUD) are serious and widespread
problems that affect approximately seventeen million Americans
[1]. Genetics and environment both make significant contributions
to the propensity to develop alcoholism [2], but the genes and
specific environmental factors influencing abuse liability remain
poorly understood. One problem with understanding the etiology
of alcoholism is defining a quantitative phenotype that is tractable
for study. The heritable phenotype of initial level of response (LR)
to ethanol is a strong predictor of the subsequent development of
alcohol use disorders [3–6], so factors influencing LR may also be
central to the development of AUD, making them particularly
attractive targets for research. Environmental risk factors alter
alcohol abuse liability through interactions with genetic predispositions [7]. While previous studies of environmental contributors to
alcoholism have considered a large variety of psychological and
social factors that influence behavior, less attention has been paid
to environmental factors that modify the physiological phenotype
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an individual’s level of response to alcohol. Previous work aimed at
identifying the mechanisms of action for ethanol has shown that
the effects of ethanol in C. elegans are largely in the nervous
system and that initial sensitivity and AFT are dependent on
proper neuronal expression of ethanol targets [8,9,16].
Recently, we observed that altering fatty acid levels in C. elegans
modulates the development of AFT, and our results suggested that
there were likely to be particular species of fatty acids that are
important for AFT [16]. Here we have focused on the role of longchain polyunsaturated fatty acids, (LC-PUFAs) in the behavioral
responses to ethanol. LC-PUFAs are enriched in the brain and
retina in mammals [18,19], and mutations that alter fatty acid
metabolism in worms have been shown affect neurotransmission
by decreasing synaptic vesicle recycling and neurotransmitter
release in C. elegans [20,21]. Fatty acid metabolism is extremely
well conserved between C. elegans and mammals, and mutations
in the fatty acid metabolic pathway in worms have been
characterized [22–24]. In this study, we assessed the role of LCPUFAs on initial sensitivity and development of AFT in C.
elegans.

Results
Long chain polyunsaturated fatty acids (LC-PUFAs) are
required for the acute behavioral response to ethanol
To determine if LC-PUFAs have a role in behavioral responses
to ethanol, we exposed mutants lacking all or some LC-PUFAs to
ethanol and assessed their locomotion behavior over a 30-minute
exposure. In this acute ethanol exposure paradigm, we can
observe both initial sensitivity (the degree to which animals are
impaired by ethanol at 10 minutes) and the development of acute
functional tolerance (AFT) to ethanol. AFT is a metabolismindependent compensation for the depressing effects of ethanol on
locomotion [9]. Initial sensitivity and AFT are components of the
acute level of response to ethanol [15,17]. The development of
AFT to the depressing effects of ethanol on locomotion speed in C.
elegans is visible as an increase in the average speed after
30 minutes of ethanol exposure compared with the measured
average speed at the initial 10-minute time point. The fat-3 gene
encodes a delta-6 fatty acid desaturase that is required for the
generation of all LC-PUFAs in worms (Figure 1A) [23]. We found
that fat-3(wa22) mutants were unable to develop AFT; unlike the
wild-type animals, the measured speeds of the fat-3 mutant
animals were not different at the 10- and 30-minute time points
(Figure 1B). This result suggests that one or more LC-PUFAs is
necessary for normal acute behavioral responses to ethanol. Both
arachidonic acid (AA) and eicosapentaenoic acid (EPA) are known
to be involved in neuronal activity [20,25], so we tested the
requirement for these specific LC-PUFAs in the ethanol response
using animals missing one or both of these fatty acids. The fat-4
gene encodes a delta-5 fatty acid desaturase, and fat-4(wa14)
mutants are unable to generate AA or EPA (Figure 1A) [26,27].
fat-4 mutant animals were unable to develop AFT to ethanol
(Figure 1C), suggesting that AA and/or EPA is required for AFT.
To distinguish between a requirement for AA or EPA, we tested
animals carrying a mutation in the fat-1 gene, which encodes an
omega-3 fatty acyl desaturase that is required for the conversion of
AA to EPA (Figure 1A). fat-1(wa9) mutants lack omega-3
arachidonic acid (O3AA) and EPA [26,28]. fat-1(wa9) mutants
were unable to develop AFT (Figure 1C), indicating that EPA
and/or O3AA is required for normal AFT. Taken together, our
data point to EPA as the LC-PUFA that is necessary for the
normal development of AFT.
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Figure 1. Long-chain polyunsaturated fatty acids are required
for the development of acute functional tolerance to ethanol.
(A) The metabolic pathway for LC-PUFAs in C. elegans. Genes encoding
enzymes responsible for each step of the generation of each LC-PUFA
are shown over the arrows. Mutations in genes encoding the enzymes
FAT-3, FAT-4 and FAT-1 eliminate downstream LC-PUFAs [23,26–28]. (B–
C) N2 animals develop acute functional tolerance (AFT) to ethanol,
whereas fat-3(wa22), fat-4(wa14), and fat-1(wa9) fail to develop AFT.
Animals were treated with 0 or 400 mM ethanol, and locomotion was
recorded at 10 and 30 minutes of exposure. Here and in subsequent
figures, left graphs show relative speeds (treated/untreated speed). A
difference at 10 minutes between N2 and the mutant indicates that the
mutant has a change in initial sensitivity; a significant increase in speed
from 10 to 30 minutes within a strain is defined as the development of
AFT. Right graphs show percent of speed recovered between 10 and
30 minutes within a strain; this is the degree of AFT. fat-3(wa22) is more
sensitive than wild type to the intoxicating effects of ethanol at
10 minutes in this set of experiments, although in subsequent
experiments, this difference did not reach statistical significance. Error
bars represent SEM. *p,0.05; **p,0.01. n = 6.
doi:10.1371/journal.pone.0105999.g001

EPA but not AA is necessary and sufficient for AFT
Dietary supplementation of PUFAs can rescue phenotypes
associated with mutations in the biosynthetic enzymes for LCPUFAs [20,21,26,29]. fat-1(wa9), fat-4(wa14), and fat-3(wa22)
mutants all display slow basal locomotion (Figure S1). Consistent
with previous studies [20,21], we found that raising fat-3 mutant
animals on medium containing AA over the course of their lifetime
restored their basal speeds to wild-type. Supplementation of AA
was also able to rescue the basal speeds of fat-4 but not fat-1
mutant animals, suggesting that the conversion of AA to EPA is
necessary for normal locomotion speeds. Consistent with this
hypothesis, supplementation of EPA was able to rescue the basal
speeds of fat-3, fat-4 and fat-1 mutant animals (Figure S1).

2
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We asked if dietary supplementation was able to restore wildtype responses to ethanol in these mutant backgrounds. fat4(wa14) mutant animals fed AA are expected to accumulate both
AA and EPA [23,27], and we found that dietary supplementation
of AA in fat-4(wa14) mutants restored their ability to develop
robust AFT (Figure 2A). EPA supplementation of fat-4(wa14)
should produce no AA [26]. EPA was also able to rescue the AFT
defect of fat-4(wa14) (Figure 2B), suggesting that EPA and not AA
is sufficient for AFT.
In order to further differentiate between the roles of AA and
EPA in AFT, we supplemented fat-1(wa9) mutants with each LCPUFA. fat-1(wa9) mutant animals lack EPA and O3AA [26]. As
expected, EPA supplementation of fat-1(wa9) rescued AFT in this
mutant (Figure 2D), suggesting that there is no requirement for
O3AA in AFT. Supplementation of AA into fat-1(wa9) mutants,
which cannot convert AA to EPA (Figure 1A) resulted in no
significant development of AFT (Figure 2C), indicating that AA
itself is insufficient to provide the LC-PUFA requirement in AFT.
To determine if EPA is the only LC-PUFA required for the
development of AFT, we supplemented EPA into the diet of fat3(wa22) worms, which lack all LC-PUFAs [23]. This supplementation has been shown to result in the accumulation of greater than
wild-type levels of EPA while not affecting the levels of gammalinolenic acid (GLA), dihomo-gamma-linolenic acid (DGLA), AA,
and O3AA [26]. Supplementation of EPA in fat-3(wa22) worms
was able to rescue the development of AFT (Figure 2E). Taken
together, these results suggest that EPA is necessary and sufficient
for the development of AFT.

LC-PUFAs are required only in adults for AFT, but are
required during development for normal basal
locomotion
LC-PUFAs are involved in neuronal development as well as in
the function of mature neurons [20,21,25,26,29,30]. To this point,
our dietary supplementation studies all provided LC-PUFAs to
animals throughout their development. In order to distinguish
between developmental or acute requirements for EPA in AFT,
we provided EPA to fat-1 mutant animals at the last larval stage
(L4), after most tissue development and differentiation has
occurred. Consistent with a model in which EPA is required for
adult neuronal function, we found that 19 hours of EPA
supplementation (only during the L4 and early adult stages) was
sufficient to rescue AFT in fat-1(wa9) (Figure 3A). This result
strongly suggests that EPA is required in the mature nervous
system for AFT, and that EPA is not required during development
to make animals capable of developing AFT.
To our surprise, we found that this late supplementation of EPA
was unable to rescue the slow basal speeds in fat-1(wa9) mutant
animals (Figure 3B), suggesting that the basal speed defects in
these animals are due to developmental requirements for EPA.
Together, these data indicate that there are at least two separable
requirements for EPA in normal adult behavior.

Figure 2. Dietary supplementation of EPA can rescue the AFT defect in mutants lacking LC-PUFAs. Animals were reared on NGM plates
containing 0.1% NP-40 and 0 or 160 mM AA (A, C, E) or 0 or 160 mM EPA (B, D, F). (A, C, E) Supplementation with AA is able to rescue the AFT defect of
fat-4(wa14) (A) and fat-3(wa22) (E), but not fat-1(wa9) (C) mutants, suggesting that the conversion of AA to EPA by FAT-1 is required for AFT. (B, D, F)
Supplementation with EPA is able to rescue AFT in fat-4(wa14) (B), fat-1(wa9) (D) and fat-3(wa22) (F), indicating that EPA is sufficient to provide all LCPUFA function that is required for AFT. Error bars represent SEM. *p,0.05; **p,0.01; ***p,0.001. n = 6 for AA supplementation and n = 5 for EPA
supplementation.
doi:10.1371/journal.pone.0105999.g002

PLOS ONE | www.plosone.org

3

August 2014 | Volume 9 | Issue 8 | e105999

Eicosapentaenoic Acid Modulates Alcohol Responses

Figure 3. Nineteen hour treatment of fat-1(wa9) with EPA rescues AFT but not basal speed defects in fat-1. N2 and fat-1(wa9) mutant
animals were grown to the L4 stage on NGM plates, then they were moved to NGM plates containing 0.1% NP-40 and supplemented with 0 or
160 mM EPA and allowed to develop into first day adults. After 19 hours of EPA supplementation, adult animals were tested in locomotion assays on 0
or 400 mM ethanol. (A) After 19 hours of EPA supplementation, fat-1(wa9) animals are able to develop AFT, whereas age-matched fat-1(wa9) animals
not supplemented with EPA do not develop AFT. (B) 19 hours of EPA supplementation is not sufficient to rescue the slow basal speed of fat-1(wa9)
mutant animals. Basal speed (0 mM ethanol) was measured at 10 and 30 minutes after the beginning of the locomotion assay. Error bars represent
SEM. **p,0.01; ***p,0.001 within treatment; ##p,0.01 for comparison of supplemented fat-1 to supplemented N2. n = 6.
doi:10.1371/journal.pone.0105999.g003

animals. We suspected that increasing the number of trials would
reveal a significant effect of dietary supplementation on wild-type
responses to ethanol. When we compiled the wild-type response
data from all supplementation experiments, we observed a
significant increase in AFT when either EPA or AA was
supplemented in N2 (Figure 4). Importantly, we observed no
change in basal speeds in these animals with dietary supplementation (Table S1), suggesting that the effect of AA and EPA on
AFT in wild-type animals is specific to the ethanol response
mechanism. These results demonstrate that the intact molecular
pathways involved in the development of AFT can be further
modulated through dietary supplementation of LC-PUFAs.

The role of EPA in cholinergic signaling is distinct from its
role in AFT
PUFAs are enriched in synaptic membranes [31] and their loss
in a fat-3 mutant results in a decrease of cholinergic neurotransmission, which can be rescued by AA supplementation [20,21].
Modulation of neurotransmission activity is a potential mechanism
for the development of AFT to ethanol. To assess if the function of
LC-PUFAs in cholinergic neurotransmission overlaps with the role
of EPA in the development of AFT, we tested the sufficiency of
dietary supplementation of AA and EPA in rescuing the
cholinergic defects of fat-1 and fat-4 mutants. The acetylcholinesterase inhibitor aldicarb inhibits the degradation of acetylcholine
and results in tonic paralysis; the time necessary for paralysis is
indicative of the amount of acetylcholine being released.
Consistent with previous reports that observed aldicarb resistance
in fat-3 mutants [20], we found that fat-1(wa9) and fat-4(wa14)
mutants are both resistant to aldicarb compared to wild-type
animals (Figure S2A). Supplementation with EPA or AA was able
to rescue aldicarb sensitivity in both mutants (Figure S2C–D)
indicating that both AA and EPA are capable of restoring normal
cholinergic signaling in animals deficient in LC-PUFAs. This is in
contrast to our finding that AA fails to rescue the AFT defect in
fat-1(wa9), and indicates that the requirements for LC-PUFAs in
AFT and cholinergic neurotransmission are not identical.

Discussion
The goal of this work was to determine if there is a role for LCPUFAs in the acute response to alcohol. We measured the effects
of acute ethanol exposure on the locomotion of C. elegans, and
found that EPA modulates the development of AFT to ethanol.
AFT is an example of neuronal plasticity, and the mechanisms
underlying AFT represent a compensatory response to the
environmental insult brought about by the actions of ethanol.
This plasticity is independent of ethanol metabolism and most
likely represents changes in neuronal function [8,10]. The effects
of fatty acids on AFT may therefore have relevance for other forms
of homeostasis and plasticity.
We found that animals that are deficient in EPA are unable to
develop AFT to ethanol. Dietary supplementation of EPA is
sufficient to restore AFT to mutant animals that are unable to
synthesize LC-PUFAs. AA is also able to modulate AFT, but only
when it can be converted to EPA. The function of EPA in AFT
appears to be independent of developmental roles of LC-PUFAs,
as providing EPA to late larval stage and adult animals is sufficient
for the generation of AFT. In contrast, LC-PUFAs are required
developmentally for normal adult speeds in the absence of ethanol.

Wild-type AFT can be modulated by dietary fatty acids
Given the strength of the effect of altering EPA levels on AFT,
dietary supplementation of EPA with wild-type animals that have
normal endogenous levels of EPA may be expected to result in an
enhancement of AFT. We noted that while supplementation of AA
or EPA into wild-type N2 did not result in statistically significant
changes in AFT in any set of the above experiments, in each case
there was a strong trend toward dietary supplementation of LCPUFAs causing an increase in the degree of AFT in wild-type

PLOS ONE | www.plosone.org

4

August 2014 | Volume 9 | Issue 8 | e105999

Eicosapentaenoic Acid Modulates Alcohol Responses

Figure 4. Dietary supplementation of AA or EPA can enhance the development of AFT in wild-type animals. All trials in which N2 was
supplemented with AA or EPA are shown, n = 21 for AA, n = 18 for EPA. (A) N2 animals supplemented with AA demonstrate increased initial sensitivity
to ethanol and enhanced development of AFT. (B) N2 animals supplemented with EPA demonstrate enhanced AFT. Error bars represent SEM. *p,
0.05; **p,0.01; ***p,0.001.
doi:10.1371/journal.pone.0105999.g004

LC-PUFA supplementation has been shown to influence cholinergic signaling possibly through interactions with synaptojanin
[21]. Intriguingly, AA and EPA can both rescue cholinergic
signaling independent of the conversion of AA to EPA. This
suggests that the role for EPA in regulating AFT is not identical to
its role in regulating cholinergic neurotransmission. Our finding
that EPA alone is required for AFT differs from published work on
other known roles of LC-PUFAs in worm behaviors. Kahn-Kirby
et al. [26] demonstrated that either EPA or AA was able to
modulate the functions of both the AWC and ASH sensory
neurons. There is a clear requirement for LC-PUFAs in growth,
basal locomotion and reproduction, because fat-3 mutant animals
have defects in these phenotypes. Both AA and EPA are able to
rescue the gross phenotypic defects in fat-3 mutant animals [29],
although this did not explicitly test a requirement for AA because
the functional fat-1 in these animals means that AA supplementation would also provide EPA in these experiments. In addition to
the requirement for EPA in AFT, there are other requirements for
specific LC-PUFAs in worms. Recently, Vasquez et al. [25]
demonstrated that AA is required for proper touch cell function in
C. elegans. Together, these diverse findings demonstrate that
different LC-PUFAs can have distinct roles in different neurobiological processes. Finally, we have shown that the manipulation
of LC-PUFA levels by dietary supplementation in wild-type
animals can alter the acute behavioral responses to ethanol.
Together, these data highlight this environmental variable as a
potential modifier of ethanol responses that are predictive of abuse
liability.
One mechanism by which EPA may modulate AFT is through
effects on membrane structure or function. Dietary omega-3 fatty
acids, such as DHA and EPA, alter both lipid raft structure and
the signaling of proteins known to reside in lipid rafts [32] and this
may have functional consequences for interacting proteins that are
involved in AFT. Lipids in the surrounding membrane modulate
PLOS ONE | www.plosone.org

the functions of many proteins that are known to respond to
ethanol. For example, we have previously identified the SLO-1
BK channel as an ethanol target in C. elegans [8], and mammalian
BK channel activity is modulated by lipids [33–39]. We identified
a genetic interaction between SLO-1 and the triacylglyceride
lipase, lips-7, suggesting that the lipid milieu can modulate BK
function in vivo in worms [16]. While modulation of SLO-1
function is not the only mechanism of AFT [16], if EPA modifies
the function of it and/or other ethanol responsive proteins directly
or indirectly though changing membrane characteristics, then the
acute behavioral response to ethanol may be modified by dietary
intake of PUFAs.
A second possibility is that LC-PUFAs are acting as signaling
molecules or as precursors to signaling molecules that modulate
ethanol responses. AA and EPA are metabolized into a variety of
signaling molecules including eicosanoids and the resolvins.
Interestingly, in C. elegans, the primary LC-PUFA precursor for
the generation of eicosanoids is EPA, whereas in humans the
primary precursor is AA [40]. While we have not yet determined if
the requirement for EPA in AFT requires its metabolism to
eicosanoids, there is increasing evidence for important roles for
LC-PUFA derived eicosanoids in behavior in worms. EPA derived
eicosanoids were found to regulate pharyngeal pumping [41], a
neuromuscular behavior that is also affected by ethanol [8].
Furthermore, LC-PUFA derived eicosanoids have been found to
be required for the behavioral response to reoxygenation after
hypoxia [42]. Very recently, prostaglandin E2 has been demonstrated to regulate the function of the BK channel in mammals
[43].
EPA could also be acting as a signaling molecule itself; KhanKirby et al. [26] demonstrated that exogenously applied EPA
could acutely rescue a TRPV-dependent sensory response in
worms, indicating that it could directly alter the function of TRPV
channels. If EPA is acting as a signaling molecule in AFT, then its
5
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day adults were acclimated by moving them to unseeded plates
with copper rings for thirty minutes. At thirty minutes ten worms
of each strain were then moved from acclimation plates to the
corresponding copper ring on the assay plate. Locomotion was
recorded at 10 and 30 minutes of exposure. Movies were made on
a Leica MZ6 stereo microscope with a 0.5x objective and 0.8x
magnification using a Retiga 4000R camera (QImaging) and
ImagePro Plus (6.2) (MediaCybernetics) software. Recordings were
made at one frame per second and the speed of each worm was
determined using ImagePro Plus software. The average speed for
each group of 10 animals was calculated and treated as a single
trial. All strains were tested a minimum of five times.

function differs from its signaling function with TRPV channels,
because Kahn-Kirby et al. [26] were able to use either EPA or AA
to modulate TRPV channels. Here we demonstrate that EPA and
not AA is required for AFT.
In humans, most omega-3 PUFAs are derived from dietary
sources, and diet can strongly influence the amount of omega-3
fatty acids in tissue reviewed in [44]. Millions of people routinely
take fish oil supplements containing EPA, which can significantly
increase plasma EPA levels [44]. There has been increasing
interest in the relationship between neurobiological disorders and
levels of omega-3 fatty acids. Several studies have demonstrated
abnormal omega-3 fatty acid metabolism in depressed patients
relative to controls [45,46], and decreases in omega-3 fatty acids
have been observed to correlate with deficiencies in dopaminergic
signaling [47]. Major depressive disorder and alcohol abuse
disorders (AUD) have been shown to be co-morbid [1,48] and the
dopamine pathway has been shown to respond profoundly to both
acute and chronic ethanol [49–53]. Although there have been few
studies on the relationship between omega-3 fatty acids and AUD,
in one study, three weeks of dietary supplementation with EPA
and DHA was found to significantly reduce stress and cortisol
levels in abstinent alcoholics [54].
There are both genetic and environmental influences on the
propensity to develop AUDs. The effect of fatty acids on ethanol
responses may also be modulated by genetics. There is a significant
genetic contribution to the acute level of response in humans [55].
Naturally occurring genetic polymorphisms in the fatty acid
metabolism enzyme-encoding genes have been shown to detectably alter lipid profiles in humans [56]. Our work suggests that
genetic variation in genes that modulate the physiological profile
of LC-PUFAs could impact the acute response to alcohol, and
therefore such genes represent potential risk loci.
Little is known about the environmental influences on the
behavioral responses to alcohol. Our data indicate that by simple
dietary supplementation with EPA, we can make measurable
changes in acute ethanol tolerance in wild-type populations in C.
elegans. In humans, acute ethanol tolerance is strongly correlated
with abuse liability. Taken together, this and previous studies
suggest that lipid metabolism and profile can influence responses
to alcohol, and provide strong evidence for diet to be considered as
a possible environmental risk factor in the liability for alcohol use
disorders.

Fatty acid supplementation
Fatty acid supplementation was performed as previously
described [26]. Fatty acid salts (arachidonate and eicosapentaenoate; Nu-Chek Prep, Elysian, MN) were diluted to 20 mM in
dH2O. NGM solutions were prepared with the addition of 0.1%
NP-40 (Sigma), autoclaved, and maintained in a 60uC water bath.
EPA or AA was added to a final concentration of 160 mM, control
plates were supplemented with an equal volume of water. Plates
were poured immediately and dried overnight at room temperature in a dark box. Plates were seeded with bacteria the following
day and stored at 20uC for 48 hours before use.
The NP-40 vehicle itself causes a decrease in the overall speed of
all animals that are exposed to it but does not affect animals in a
genotype specific manner (Table S1). In each experiment using
NP-40, the control animals were reared on plates containing NP40 to account for this general slowing.

Age synchronization
Egg laying: First day adult worms were allowed to lay eggs for
two hours on seeded NGM or fatty acid supplemented plates. The
adults were then removed and eggs were allowed to hatch and
develop to first day adults before assaying.

Assessment of ethanol response
A relative speed for each time point is calculated by dividing the
speed of animals on ethanol (treated speed) by the speed of animals
of the same genotype at the same time points on 0 mM ethanol
(untreated speed). Strains that were compared were tested in
parallel at the same time. We assess initial sensitivity by comparing
the ten minute relative speeds between strains. A statistical
difference in the speeds reflects a significant change in the initial
sensitivity. We define a statistically significant increase in the
relative speed at 30 minutes versus 10 minutes as the development
of AFT. Degree of AFT is quantified as percent recovery of speed
and is calculated by subtracting the 10-minute relative speed from
the 30-minute relative speed.

Experimental Procedures
Nematode husbandry
Unless otherwise noted, strains were maintained on nematode
growth media (NGM) plates at 20uC. Before use, NGM plates
were seeded with OP50 E. coli and a lawn of bacteria was allowed
to grow overnight at room temperature. Strains used in this study
were: Wild-type N2 (var Bristol), BX24 fat-1(wa9), BX17 fat4(wa14), BX30 fat-3(wa22).

Statistics
Animals that were compared to each other were treated on the
same plate at the same time under identical conditions. Data were
converted to relative speeds to account for basal speed differences
between strains (Table S1). Statistics were performed using Prism
5.0 (GraphPad). For comparisons of a single strain or treatment to
a control, two-tail paired t-tests were performed. When multiple
comparisons were necessary, as in the fatty acid supplementation
assays, one-way ANOVA with a Dunnett’s post hoc test was used.
Aldicarb assays were analyzed by two-way ANOVA with a
Bonferroni post-hoc test.

Locomotion tracking
Speed was analyzed as described previously [9] with minor
changes: Assay plates (NGM) were dried for one hour at 37uC with
the lids removed. Four copper rings were heated and melted into
the surface of the agar. For ethanol treatment plates, ice-cold
100% ethanol was added to a final concentration in agar of
400 mM. Previously, we showed that a 10-minute 400 mM
exogenous ethanol exposure produces a tissue concentration of
ethanol of approximately 44–67 mM [10]. Plates were immediately sealed with Parafilm and the ethanol was left to absorb into
the plate for two hours at room temperature. Age-matched first
PLOS ONE | www.plosone.org
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supplementation do not alter aldicarb sensitivity in N2. (C–D)
The aldicarb resistance of fat-4(wa14) mutant animals is rescued
by dietary supplementation of either EPA or AA. (D) The aldicarb
resistance of fat-1(wa9) is rescued by EPA or AA, demonstrating
that AA alone is able to function to restore ACh signaling in
animals lacking both AA and EPA. Filled symbols indicate time
points that are statistically different (at least p,0.05) from N2 in
(A), and from the non-supplemented animals in (B, C and D). (E)
Dietary supplementation of AA or EPA are able to rescue the
aldicarb resistance phenotypes of fat-1 and fat-4 animals at the
180 minute time point, while N2 is unaffected by the supplementation. *p,0.05; ***p,0.001 for comparison of unsupplemented
mutant to supplemented mutant. Error bars represent SEM. n = 3.
(PDF)

Aldicarb assay
Plates containing 1 mM aldicarb (Sigma) were prepared fresh
for each set of paralysis assays as described previously [57].
Twenty adult animals were scored per experiment and three
independent experiments were carried out [58]. Worms were
scored at 30-minute intervals for three hours. They were counted
as paralyzed if they were unable to respond to any of three pokes
with a platinum wire on the head and tail.

Supporting Information
Figure S1 EPA is required for normal speed of locomotion.
Worms were reared on 0 or 160 mM AA (left graphs) or 0 or
160 mM EPA (right graphs) supplemented NGM plates containing
0.1% NP-40, and locomotion of first day adults was assessed. (A)
fat-3(wa22) mutant animals lack all LC-PUFAs and have a slow
locomotion phenotype. Dietary supplementation with AA (left) or
EPA (right) can restore locomotion to wild-type speed. (B) fat4(wa14) mutant animals lack AA and EPA, and dietary
supplementation by either AA or EPA can restore wild-type
locomotion speed. (C) fat-1(wa9) mutant animals lack EPA and
cannot convert AA to EPA. Dietary supplementation with EPA
but not AA is able to restore wild-type locomotion speeds to fat-1
mutants, indicating that EPA is required for normal locomotion
speed. Error bars represent SEM. **p,0.01; ***p,0.001 for
comparison of unsupplemented mutant to unsupplemented N2;
###p,0.001 for comparison of supplemented mutant to
supplemented N2; $$p,0.01, $$$p,0.001 for comparison of
unsupplemented mutant to supplemented mutant. n = 6 for AA
supplementation and n = 5 for EPA supplementation.
(PDF)

Table S1 Raw locomotion data for all experiments. The raw
locomotion data that is used to generate the relative speed
measurements is presented. Each experiment includes an experimental group and its paired controls, which were reared in
identical conditions and tested on the same plates at the same time.
The treated and untreated animals for a given experiment were
tested on the same day. There is some day-to-day variation in the
absolute speeds of animals. In addition, the presence of NP-40 on
the culture plates causes a general slowing of all genotypes of
animals. In each case, the relative numbers that we present in the
figures and text are derived from the experimental and their
paired control animal data.
(PDF)
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acetycholine (ACh) release. Worms were treated with 1 mM
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